Myovant Sciences Completes Patient Recruitment for Phase 3 SPIRIT 1 Study Evaluating Relugolix Combination Therapy in Women with Endometriosis
Top-line results for SPIRIT 2 and SPIRIT 1 expected in the first and second quarters of 2020, respectivelyStudies support potential […]